PCBs May Increase Risk of Autism, Researchers Say

Exposure to polychlorinated biphenyl, most commonly known as PCBs, could increase a child’s risk of developing an autism spectrum disorder, according to new research. 

In a study published in the journal Environmental Health Perspectives, researchers from the University of California – Davis and Washington State University found that PCBs promote neural irregularities that could be the deciding factor of whether children with a genetic propensity towards autism actually manifest the disorder.

The researchers found that PCBs cause a chain of events in the brain that results in overproduction of dentrites, which are strands of material that help signals in the brain transmit between neurons. If these dentrites grow out of control it can impair neural connectivity, which is a condition related to disorders on the autism spectrum.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

While researchers say that their studies do not indicate that PCBs cause children to develop autism, they could be the final push for children who have the genetic tendency already.

The study involved the use of baby rats who were breastfed by mother rats who had been exposed to PCBs. The chemicals appeared to trigger increased calcium levels in neurons, resulting in dentrite growth.

PCBs were used for decades in dielectric and coolant fluids in electrical motors, transformers, and capacitors. It was eventually determined to be toxic and PCB spills, clean-up sites and the landfills created to dispose of the chemicals were a crucial part of the birth of the environmentalist movement in the United States.

Production of PCBs was banned in the U.S. in 1979 and later worldwide in the Stockholm Convention on Persistent Organic Pollutants in 2001.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

In the first federal trial over claims of Uber driver sexual assaults, a lawsuit involving the rape of a passenger will go before a jury on January 13.
More than 2,000 Depo-Provera brain tumor lawsuits have been filed in state and federal courts nationwide, according to recent court documents, with potentially thousands more claims pending.
A federal judge will meet with lead counsel in the Suboxone litigation tomorrow to receive an update on the number of Suboxone lawsuits filed and the status of discovery.